Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0895
Source ID: NCT01200784
Associated Drug: Nicotinamide
Title: Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
Acronym: DONATO
Status: COMPLETED
Study Results: NO
Results:
Conditions: Chronic Kidney Disease|Hemodialysis|Hyperphosphatemia
Interventions: DRUG: Nicotinamide
Outcome Measures: Primary: serum phosphate, 4 weeks of active treatment | Secondary: serum phosphate, 8 weeks of active treatment|serum calcium, 4 and 8 weeks of acitve treatment|serum PTH, 4 and 8 weeks of active treatment|adverse events, 12 weeks
Sponsor/Collaborators: Sponsor: Medice Arzneimittel Pütter GmbH & Co KG
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 252
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2010-08
Completion Date: 2011-07
Results First Posted:
Last Update Posted: 2012-01-18
Locations: Alsfeld, 36304, Germany|Arnstadt, 99310, Germany|Augsburg, 86157, Germany|Berlin Hellersdorf, 12627, Germany|Berlin Kreuzberg, 10245, Germany|Berlin, 12045, Germany|Berlin, 12203, Germany|Berlin, 12435, Germany|Berlin, 13051, Germany|Bielefeld, 33602, Germany|Coburg, 96450, Germany|Darmstadt, 64295, Germany|Dortmund, 44135, Germany|Dülmen, 48249, Germany|Düsseldorf, 40210, Germany|Elsenfeld, 63820, Germany|Erfurt, 99089, Germany|Essen, 45127, Germany|Friedrichsroda, 99894, Germany|Hamburg, 22297, Germany|Hameln, 31787, Germany|Herne, 44623, Germany|Herzberg, 04916, Germany|Iserlohn, 58638, Germany|Jena-Drakendorf, 07751, Germany|Kamen, 59174, Germany|Leverkusen, 51373, Germany|Mannheim, 68309, Germany|Minden, 32429, Germany|Nordhausen, 99734, Germany|Osnabrueck, 49074, Germany|Pfarrkirchen, 84347, Germany|Regensburg, 93053, Germany|Schwabach, 91126, Germany|Tangermünde, 39590, Germany|Wuppertal, 42283, Germany
URL: https://clinicaltrials.gov/show/NCT01200784